Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: Biological correlates of clinical outcome

European Journal of Cancer

Volumn 35, Issue 13, 1999, Pages 1809-1815

  Cattelan, A M ^a   Calabro', M L ^b   Aversa, S M L ^a   Zanchetta, M ^b   Meneghetti, F ^a   De Rossi, A ^b   Chieco Bianchi, L ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b AIDS Reference Center   (Italy)

Author keywords

HAART; HHV 8 antibodies; HIV 1; Kaposi's sarcoma; Protease inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; VIRUS PROTEIN; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY TITER; ARTICLE; DISEASE COURSE; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; DRUG COMBINATIONS; HERPESVIRUS 8, HUMAN; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; SARCOMA, KAPOSI; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0032760627     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00161-6     Document Type: Article

References (36)

1. Goedert J.J., Cote T.R., Virgo P.et al. Spectrum of AIDS-associated malignant disorders. Lancet. 351:1998;1833-1839.
2. Mitsuyasu R.T. Clinical aspects of AIDS-related Kaposi's sarcoma. Curr. Opin. Oncol. 5:1993;835-844.
3. Ensoli B., Bonaguro L., Barillari G.et al. Release, uptake and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287.
4. Ensoli B., Gendelman R., Markham P.et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 371:1994;674-680.
5. Gallo R.C. Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma. J. Natl. Cancer Inst. Monogr. 23:1998;55-57.
6. Chang Y., Cesarman E., Pessin M.S.et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
7. Huang Y.Q., Li J.J., Kaplan M.H.et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet. 345:1995;759-761.
8. Schulz T.F., Boshoff C.H., Weiss R.A. HIV infection and neoplasia. Lancet. 348:1996;587-591.
9. Whitby D., Boshoff C. Kaposi's sarcoma herpesvirus as a new paradigm for virus-induced oncogenesis. Curr. Opin. Oncol. 10:1998;405-412.
10. Harrington W., Sieczkowski L., Sosa C.et al. Activation of HHV-8 by HIV-1 Tat. Lancet. 349:1997;774-775. (letter).
11. Monfardini S., Tirelli U., Vaccher E. Treatment of acquired immunodeficiency syndrome (AIDS)-related cancer. Cancer Treat. Rev. 20:1994;149-172.
12. Cai J., Tulpule A., Zheng T., Masood R., Espina B., Gill P.S. Treatment of epidemic (AIDS-related) Kaposi's sarcoma. Curr. Opin. Oncol. 9:1997;433-439.
13. Gill P.S., Miles S.A., Mitsuyasu R.T.et al. Phase 1 AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 8:1994;1695-1699.
14. Jacobson M.A., French M. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS. 12(Suppl. 12):1998;S157-S164.
15. Murphy M., Armstrong D., Sepkowitz K.A., Ahkami R.N., Myskowski P.L. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor. AIDS. 11:1997;261-262. (letter).
16. Conant M.A., Opp K.M., Poretz D., Mills R.G. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir. AIDS. 11:1997;1300-1301. (letter).
17. Blum L., Pellet C., Agbalika F.et al. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy. AIDS. 11:1997;1653-1655. (letter).
18. Burdick A.E., Carmichael C., Rady P.L., Tyring S.K., Badiavas E. Resolution of Kaposi's sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitors therapy. J. Am. Acad. Dermatol. 37:1997;648-649. (letter).
19. Aboulafia D.M. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy. Mayo Clin. Proc. 73:1998;439-443.
20. Lebbe' C., Blum L., Pellet C.et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS. 12:1998;F45-F49.
21. Krown S.E., Metroka C., Wernz J.C. for the AIDS Clinical Trials Group Oncology Committe Kaposi's sarcoma in the acquired immune deficiency syndrome. a proposal for uniform evaluation, response and staging criteria J. Clin. Oncol. 7:1989;1201-1207.
22. Krown S.E., Testa M.A., Huang J. for the AIDS Clinical Trials Group Oncology Committee AIDS-related Kaposi's sarcoma. prospective validation of the AIDS clinical trials group staging classification J. Clin. Oncol. 15:1997;3085-3092.
23. Aversa S.M.L., Cattelan A.M., Salvagno L., Chiarion-Sileni V., Carretta M., Fiorentino M. Treatment of HIV-associated Kaposi's sarcoma. Proc. Am. Soc. Clin. Oncol. 14:1995;291. (abstract 831).
24. Carpenter C.C.J., Fischl M.A., Hammer S.M.et al. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. J. Am. Med. Assoc. 276:1996;146-154.
25. Carpenter C.C.J., Fischl M.A., Hammer S.M.et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. J. Am. Med. Assoc. 277:1997;1962-1969.
26. Simpson G.R., Schulz T.F., Whitby D.et al. Prevalence of Kaposi's sarcoma-associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet. 348:1996;1133-1138.
27. Calabro' M.L., Sheldon J., Favero A.et al. Seroprevalence of Kaposi's sarcoma-associated Herpesvirus/Human Herpesvirus 8 in several regions of Italy. J. Hum. Virol. 1:1998;207-213.
28. Snedecor G.W., Cochran W.G. Statistical Methods. 6th edn. 1967;Iowa State University Press, Ames.
29. McGarvey M.E., Tulpule A., Cai J.et al. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma. Curr. Opin. Oncol. 10:1998;413-421.
30. Iurlaro M., Benelli R., Masiello L., Rosso M., Santi L., Albini A. Beta interferon inhibits HIV-1 Tat-induced angiogenesis. synergism with 13-cis retinoic acid Eur. J. Cancer. 34:1998;570-576.
31. Hermans P., Clumeck N., Picard O.et al. AIDS-related Kaposi's sarcoma patients with visceral manifestations. response to human chorionic gonadotropin preparations J. Hum Virol. 1:1998;82-89.
32. Tavio M., Nasti G., Simonelli C.et al. Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma. Eur. J. Cancer. 34:1998;1634-1637.
33. Autran B., Carcelain G., Li T.S.et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 277:1997;112-116.
34. Neipel F., Albrecht J.C., Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8. determinants of its pathogenicity? J. Virol. 71:1997;4187-4192.
35. Lee H., Veazey R., Williams K.et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nature Med. 4:1998;435-440.
36. Muralidhar S., Pumfery A.M., Hassani M.et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J. Virol. 72:1998;4980-4988.